Sight Sciences EVP sells shares to cover RSU taxes

Sight Sciences EVP of Operations & R&D Taylor Brenton reported a small open-market sale of company stock primarily to cover taxes on vesting equity.

Rhea-AI Filing Summary

Sight Sciences EVP of Operations & R&D Taylor Brenton reported a small open-market sale of company stock primarily to cover taxes on vesting equity. Brenton sold 2,829 shares of common stock at a weighted average price of $5.42 per share in multiple transactions.

The shares were sold to satisfy tax liabilities arising from the vesting of restricted stock units rather than as a discretionary portfolio move. After these sales, Brenton’s reported holdings total 264,978 shares, including 36,696 shares of common stock and 228,282 shares that will be received upon future RSU vesting and settlement.

Insider Trade Summary 10b5-1

Net Seller: 2,829 shares

Net Sell 1 txn

Insider Taylor Brenton

Role EVP, Operations & R&D

Sold 2,829 shs ($15K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,829	$5.42	$15K

Holdings After Transaction: Common Stock — 264,978 shares (Direct)

Footnotes (3)

1. F1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. F2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. Includes (i) 36,696 shares of Common Stock, and (ii) 228,282 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 2,829 shares Weighted average sale price: $5.42 per share Shares held after transaction: 264,978 shares +2 more

5 metrics

Shares sold 2,829 shares Open-market sale on 2026-07-01 to cover RSU tax liability

Weighted average sale price $5.42 per share Average price across multiple transactions ranging from $5.24 to $5.58

Shares held after transaction 264,978 shares Total common stock beneficially owned following the reported sale

Current common stock holdings 36,696 shares Portion of post-transaction holdings that are already-issued common shares

Unvested RSUs 228,282 shares Shares to be acquired upon future vesting and settlement of RSUs

Key Terms

restricted stock units ("RSUs"), weighted average price, vesting and settlement

3 terms

restricted stock units ("RSUs") financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting and settlement financial

"which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sight Sciences (SGHT) report for Taylor Brenton?

Sight Sciences reported that EVP of Operations & R&D Taylor Brenton sold 2,829 shares of common stock. The sale was made in open-market transactions primarily to cover tax liabilities linked to the vesting of restricted stock units (RSUs).

At what price did Taylor Brenton sell Sight Sciences (SGHT) shares?

Taylor Brenton’s 2,829 Sight Sciences shares were sold at a weighted average price of $5.42 per share. Footnotes state the individual trades occurred at prices ranging from $5.24 to $5.58, with the exact breakdown available upon request.

How many Sight Sciences (SGHT) shares does Taylor Brenton hold after this sale?

After the sale, Taylor Brenton holds 264,978 Sight Sciences shares. This total includes 36,696 shares of common stock and 228,282 additional shares that will be acquired when currently unvested restricted stock units (RSUs) vest and settle in the future.

Why did Taylor Brenton sell Sight Sciences (SGHT) shares in this Form 4?

The shares were sold to cover the tax liability arising from vesting restricted stock units. This means the transaction is primarily a tax-related event associated with equity compensation, rather than a purely discretionary decision to reduce exposure to Sight Sciences stock.

Were Taylor Brenton’s Sight Sciences (SGHT) share sales part of multiple transactions?

Yes. The 2,829 shares sold were executed in multiple trades on the same day. A weighted average sale price of $5.42 per share is disclosed, with individual prices ranging from $5.24 to $5.58, and detailed trade information available upon request.

Does Taylor Brenton still have unvested equity in Sight Sciences (SGHT)?

Yes. Brenton retains 228,282 shares of Sight Sciences that will be acquired upon the vesting and settlement of restricted stock units. These unvested RSUs are in addition to 36,696 already-owned common shares, supporting a sizeable remaining equity position after the tax-related sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 07:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Brenton

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Operations & R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S		2,829(1)	D	$5.42(2)	264,978(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 36,696 shares of Common Stock, and (ii) 228,282 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for Brenton Taylor	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)